JRCT ID: jRCT2080223866
Registered date:10/04/2018
-
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 27/04/2018 |
| Target sample size | 92 |
| Countries of recruitment | Japan,Asia except Japan,North America,Europe |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : - Generic name etc : - INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : - control material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : - |
Outcome(s)
| Primary Outcome | safety |
|---|---|
| Secondary Outcome | efficacy pharmacokinetics pharmacodynamics |
Key inclusion & exclusion criteria
| Age minimum | >= 18age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | - |
|---|---|
| Secondary Sponsor | - |
| Source(s) of Monetary Support | - |
| Secondary ID(s) | NCT02740270,JapicCTI-183922 |
Contact
| Public contact | |
| Name | |
| Address | - |
| Telephone | +81-120-003-293 |
| Affiliation | Novartis Pharma K.K. |
| Scientific contact | |
| Name | |
| Address | - |
| Telephone | +81-120-003-293 |
| - | |
| Affiliation | Novartis Pharma K.K. |